ZA896942B - Allelic variants of plasmodium falciparum merozoite surface antigen - Google Patents
Allelic variants of plasmodium falciparum merozoite surface antigenInfo
- Publication number
- ZA896942B ZA896942B ZA896942A ZA896942A ZA896942B ZA 896942 B ZA896942 B ZA 896942B ZA 896942 A ZA896942 A ZA 896942A ZA 896942 A ZA896942 A ZA 896942A ZA 896942 B ZA896942 B ZA 896942B
- Authority
- ZA
- South Africa
- Prior art keywords
- terminal
- surface antigen
- plasmodium falciparum
- merozoite surface
- sequences
- Prior art date
Links
- 101710203310 Apical membrane antigen 1 Proteins 0.000 title abstract 2
- 241000223960 Plasmodium falciparum Species 0.000 title abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 210000004899 c-terminal region Anatomy 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- APCLRHPWFCQIMG-UHFFFAOYSA-N 4-(5,6-dimethoxy-1-benzothiophen-2-yl)-4-oxobutanoic acid Chemical compound C1=C(OC)C(OC)=CC2=C1SC(C(=O)CCC(O)=O)=C2 APCLRHPWFCQIMG-UHFFFAOYSA-N 0.000 abstract 1
- 101150092365 MSA2 gene Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 abstract 1
- 101100240989 Schizosaccharomyces pombe (strain 972 / ATCC 24843) nrd1 gene Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000004897 n-terminal region Anatomy 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
- C12N9/1088—Glutathione transferase (2.5.1.18)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPJ038288 | 1988-09-12 | ||
| AUPJ596289 | 1989-08-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA896942B true ZA896942B (en) | 1990-08-29 |
Family
ID=25643542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA896942A ZA896942B (en) | 1988-09-12 | 1989-09-12 | Allelic variants of plasmodium falciparum merozoite surface antigen |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0433378B1 (da) |
| JP (1) | JPH04500668A (da) |
| KR (1) | KR900701831A (da) |
| AT (1) | ATE129504T1 (da) |
| DE (1) | DE68924649D1 (da) |
| DK (1) | DK43991A (da) |
| IL (1) | IL91609A0 (da) |
| WO (1) | WO1990002752A1 (da) |
| ZA (1) | ZA896942B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0434751A1 (en) * | 1988-09-16 | 1991-07-03 | Statens Seruminstitut | A malaria antigen |
| FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
| US20030161840A1 (en) | 1992-10-19 | 2003-08-28 | Institut Pasteur | Plasmodium falciparum antigens inducing protective antibodies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4767622A (en) * | 1983-08-19 | 1988-08-30 | University Of Illinois | Method and materials for development of immunological responses protective against malarial infection |
| JPS61107292A (ja) * | 1984-10-30 | 1986-05-26 | 株式会社東芝 | 出力装置 |
| AU595056B2 (en) * | 1986-07-17 | 1990-03-22 | Program For Appropriate Technology In Health (Path) | Merozoite surface antigen of plasmodium falciparum |
-
1989
- 1989-09-12 ZA ZA896942A patent/ZA896942B/xx unknown
- 1989-09-12 DE DE68924649T patent/DE68924649D1/de not_active Expired - Lifetime
- 1989-09-12 AT AT89910586T patent/ATE129504T1/de not_active IP Right Cessation
- 1989-09-12 IL IL91609A patent/IL91609A0/xx unknown
- 1989-09-12 EP EP89910586A patent/EP0433378B1/en not_active Expired - Lifetime
- 1989-09-12 JP JP1509913A patent/JPH04500668A/ja active Pending
- 1989-09-12 WO PCT/AU1989/000388 patent/WO1990002752A1/en active IP Right Grant
-
1990
- 1990-05-12 KR KR1019900700996A patent/KR900701831A/ko not_active Application Discontinuation
-
1991
- 1991-03-12 DK DK043991A patent/DK43991A/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK43991D0 (da) | 1991-03-12 |
| EP0433378A1 (en) | 1991-06-26 |
| KR900701831A (ko) | 1990-12-04 |
| ATE129504T1 (de) | 1995-11-15 |
| EP0433378A4 (en) | 1991-11-06 |
| DK43991A (da) | 1991-05-08 |
| DE68924649D1 (de) | 1995-11-30 |
| JPH04500668A (ja) | 1992-02-06 |
| WO1990002752A1 (en) | 1990-03-22 |
| IL91609A0 (en) | 1990-04-29 |
| EP0433378B1 (en) | 1995-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68924162D1 (de) | Stressproteine und verwendungen dafür. | |
| PT101052A (pt) | Proteinas hibridas uteis na preparacao de vacinas | |
| DE69829668D1 (de) | Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe | |
| DK0423302T3 (da) | Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner | |
| DE3588254D1 (de) | Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen | |
| PT100781A (pt) | Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas | |
| DE69922958D1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
| IL70776A (en) | Recombinant dna molecule encoding at least one polypeptide displaying the immunogenicity of at least one merozoite antigen or asexual blood stage antigen of p.falciparum,vectors comprising the dna molecule,host cells transformed thereby,immunogenic polypeptides produced by host cells and compositions containing the polypeptides | |
| ATE80310T1 (de) | Antigenische proteine, dieselben enthaltende vakzine, schuetzende antikoerper dagegen fuer die verhuetung von durch eimeria tenella verursachte coccidiosis. | |
| IL70800A (en) | Peptide comprising a repetitive amino acid sequence of the immunodominant epitope of plasmodium circumsporozoite protein | |
| DK0425082T3 (da) | Vacciner | |
| IL75788A (en) | Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein | |
| DK0439056T3 (da) | Coccidiose-vacciner | |
| EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
| EP0369816A3 (en) | Monoclonal antibodies specific for human polymorphic epithelial mucin | |
| IL91609A0 (en) | Allelic variants of plasmodium falciparum merozoite surface antigen | |
| KR890006253A (ko) | 가금류내의 E.coli septicaemia에 대한 백신 | |
| GB2244273A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. | |
| MY106940A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. | |
| GR3003754T3 (da) | ||
| ES2006730A6 (es) | Un metodo de preparar un peptido o polipeptido sintetico que presenta la antigenicidad de la totalidad o una parte de un antigeno de p. falciparum | |
| DE69928947D1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
| AU660437B2 (en) | Protective plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens HRPII and SERP, the preparation and use thereof | |
| KR890000106A (ko) | 원생성 기생충 예방용 백신 | |
| Mountford et al. | Fractionation of schistosome antigens by high performance electrophoretic chromatography and their screening for the ability to induce Th1 lymphocyte activity |